Literature DB >> 24560818

EAU policy on live surgery events.

Walter Artibani1, Vincenzo Ficarra2, Ben J Challacombe3, Clement-Claude Abbou4, Jens Bedke5, Rafael Boscolo-Berto6, Maurizio Brausi7, Jean J M C H de la Rosette8, Serdar Deger9, Louis Denis10, Giorgio Guazzoni11, Bertrand Guillonneau12, John P F A Heesakkers13, Didier Jacqmin14, Thomas Knoll15, Luis Martínez-Piñeiro16, Francesco Montorsi11, Alexander Mottrie17, Pierre-Thierry Piechaud18, Abhay Rane19, Jens Rassweiler20, Arnulf Stenzl5, Jeroen Van Moorselaar21, Roland F Van Velthoven22, Hendrik van Poppel23, Manfred Wirth24, Per-Anders Abrahamsson25, Keith F Parsons26.   

Abstract

CONTEXT: Live surgery is an important part of surgical education, with an increase in the number of live surgery events (LSEs) at meetings despite controversy about their real educational value, risks to patient safety, and conflicts of interest.
OBJECTIVE: To provide a European Association of Urology (EAU) policy on LSEs to regulate their organisation during urologic meetings. EVIDENCE ACQUISITION: The project was carried out in phases: a systematic literature review generating key questions, surveys sent to Live Surgery Panel members, and Internet- and panel-based consensus finding using the Delphi process to agree on and formulate a policy. EVIDENCE SYNTHESIS: The EAU will endorse LSEs, provided that the EAU Code of Conduct for live surgery and all organisational requirements are followed. Outcome data must be submitted to an EAU Web-based registry and complications reported using the revised Martin criteria. Regular audits will take place to evaluate compliance as well as the educational role of live surgery.
CONCLUSIONS: This policy represents the consensus view of an expert panel established to advise the EAU. The EAU recognises the educational role of live surgery and endorses live case demonstration at urologic meetings that are conducted within a clearly defined regulatory framework. The overriding principle is that patient safety must take priority over all other considerations in the conduct of live surgery. PATIENT
SUMMARY: Controversy exists regarding the true educational value of live surgical demonstrations on patients at surgical meetings. An EAU committee of experts developed a policy on how best to conduct live surgery at urologic meetings. The key principle is to ensure safety for every patient, including a code of conduct and checklist for live surgery, specific rules for how the surgery is organised and performed, and how each patient's results are reported to the EAU. For detailed information, please visit www.uroweb.org.
Copyright © 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  EAU guidelines; EAU policy; Live broadcasts; Live surgery; Surgical education; Surgical procedures; Urology surgical procedures

Mesh:

Year:  2014        PMID: 24560818     DOI: 10.1016/j.eururo.2014.01.028

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  13 in total

1.  Assessment of Factors Associated With Internal Carotid Injury in Expanded Endoscopic Endonasal Skull Base Surgery.

Authors:  Abdulaziz AlQahtani; Nyall R London; Paolo Castelnuovo; Davide Locatelli; Aldo Stamm; Aaron A Cohen-Gadol; Hussam Elbosraty; Roy Casiano; Jacques Morcos; Ernesto Pasquini; Georgio Frank; Diego Mazzatenta; Garni Barkhoudarian; Chester Griffiths; Daniel Kelly; Christos Georgalas; Narayanan Janakiram; Piero Nicolai; Daniel M Prevedello; Ricardo L Carrau
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-04-01       Impact factor: 6.223

2.  Live surgery: highly educational or harmful?

Authors:  B Rocco; A A C Grasso; E De Lorenzis; J W Davis; C Abbou; A Breda; T Erdogru; R Gaston; I S Gill; E Liatsikos; B Oktay; J Palou; T Piéchaud; J U Stolzenburg; Y Sun; G Albo; H Villavicencio; X Zhang; V Disanto; P Emiliozzi; V Pansadoro
Journal:  World J Urol       Date:  2017-11-09       Impact factor: 4.226

3.  Live surgery in reconstructive urology: evaluation of the surgical outcome and educational benefit of the international meeting on reconstructive urology (IMORU).

Authors:  Victor M Schuettfort; Jessica Schoof; Clemens M Rosenbaum; Tim A Ludwig; Malte W Vetterlein; Sami-Ramzi Leyh-Bannurah; Valentin Maurer; Christian P Meyer; Roland Dahlem; Margit Fisch; Christoph-Philip Reiss
Journal:  World J Urol       Date:  2019-02-11       Impact factor: 4.226

Review 4.  Safety and effectiveness of live broadcast of surgical procedures: systematic review.

Authors:  Mina Awad; Manish Chowdhary; Shady Hermena; Sara El Falaha; Naim Slim; Nader K Francis
Journal:  Surg Endosc       Date:  2022-05-23       Impact factor: 3.453

5.  Anatomical societies find new ways to come together in a post-Covid world.

Authors:  Rafael Boscolo-Berto; Andrea Porzionato; Carla Stecco; Veronica Macchi; Raffaele De Caro
Journal:  Anat Sci Educ       Date:  2021-11-17       Impact factor: 6.652

6.  Outcome from 5-year live surgical demonstrations in urinary stone treatment: are outcomes compromised?

Authors:  Jaap D Legemate; Stefano P Zanetti; Joyce Baard; Guido M Kamphuis; Emanuele Montanari; Olivier Traxer; Jean Jmch de la Rosette
Journal:  World J Urol       Date:  2017-05-18       Impact factor: 4.226

7.  On generic prescriptions and live surgeries.

Authors:  Rajeev Kumar
Journal:  Indian J Urol       Date:  2017 Jul-Sep

8.  Surgical teaching in urology: patient safety and educational value of 'LIVE' and 'SEMI-LIVE' surgical demonstrations.

Authors:  Jaap D Legemate; Stefano P Zanetti; Jan Erik Freund; Joyce Baard; Jean J M C H de la Rosette
Journal:  World J Urol       Date:  2018-04-21       Impact factor: 4.226

9.  Live-case demonstrations in pediatric urology: Ethics, patient safety, and clinical outcomes from an 8-year institutional experience.

Authors:  Ciro Andolfi; Mohan S Gundeti
Journal:  Investig Clin Urol       Date:  2020-01-31

10.  Surgery: protecting patients during live urological surgery.

Authors:  Matthew Brown; Prokar Dasgupta
Journal:  Nat Rev Urol       Date:  2014-04-08       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.